Wonbiogen Facility Investment Period Extension Amendment, No Shareholder Value Impact
Wonbiogen originally resolved on August 26, 2025, to invest in new facilities to increase production of hydrocolloid-based products. The completion date has been amended from June 30, 2026 to July 31, 2026 due to a construction period extension.
The total investment amount remains KRW 3.6058 billion, representing 9.68% of equity, excluding VAT and land acquisition costs as the building will be expanded on previously acquired land. The unchanged investment purpose and scale limit the impact on existing funding plans.
[AI Summary]This amendment is a mere schedule adjustment with no change in investment amount or capital structure. It has no direct impact on Wonbiogen's stock price or corporate value, and does not impair the credibility of the original investment plan.
KOSDAQ Filing Information
[Correction of Description] Investment in New Facilities, etc. (Voluntary Disclosure)